Showing results (121-130 of 196) with videos related to
Sort By:
Pageof 20
Endoscopy|April 7, 2018
Factors associated with delayed bleeding after resection of large nonpedunculated colorectal polypsTimothy R Elliott, Zacharias P Tsiamoulos, Siwan Thomas-Gibson, et al.Gastrointestinal Endoscopy|December 28, 2010
Development and validation of a training module on the use of narrow-band imaging in differentiation of small adenomas from hyperplastic colorectal polypsAna Ignjatovic, Siwan Thomas-Gibson, James E East, et al.Endocrine Journal|June 14, 2003
Physiologic role of decidual beta1 integrin and focal adhesion kinase in embryonic implantationHideki Hanashi, Shigetatsu Shiokawa, Yoshihiro Akimoto, et al.FEBS Open Bio|August 14, 2021
Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathwaysNoriko Suzuki-Kemuriyama, Akari Abe, Sae Nakane, et al.American Journal of Hypertension|April 26, 2008
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive ratsNaohiko Kobayashi, Tomoyuki Ohno, Kohtaro Yoshida, et al.Digestion|February 6, 2020
Feasibility and Safety of Endoscopic Submucosal Dissection for Recurrent Rectal Lesions that after Transanal Endoscopic Microsurgery: A Case SeriesNobuaki Ikezawa, Takashi Toyonaga, Shinwa Tanaka, et al.Biological & Pharmaceutical Bulletin|June 13, 2012
Inhibition of aquaporin-3 water channel in the colon induces diarrheaNobutomo Ikarashi, Risako Kon, Tomohiko Iizasa, et al.The Journal of Pharmacology and Experimental Therapeutics|August 31, 2017
FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for SchizophreniaKeiji Nishiyama, Hirobumi Suzuki, Toshiya Harasawa, et al.Japanese Journal of Infectious Diseases|May 1, 2018
Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its HemagglutininTomoko Kuwahara, Emi Takashita, Seiichiro Fujisaki, et al.Investigational New Drugs|June 4, 2024
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumorsNoboru Yamamoto, Yasutoshi Kuboki, Kenichi Harano, et al.Pageof 20